Delivery Order SPE2DR25D2002-SPE2DR26FBRS2
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,108.65 on September 9, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens. This firm fixed-price delivery order, which is not set-aside and competitively awarded, is scheduled for completion by September 10, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,205.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on October 24, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government. The order will be fulfilled from the...
- The Defense Logistics Agency awarded a delivery order valued at $2,444.91 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens on July 16, 2025, with completion scheduled for July 17, 2025. This competitively awarded, firm fixed-price delivery order represents a single-unit pharmaceutical transaction under AmerisourceBergen's existing contract vehicle with DLA. The contractor, headquartered in Conshohocken, Pennsylvania, will fulfill this order at its corporate office...
- The Defense Logistics Agency awarded a $1,584.34 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. This firm fixed-price, non-competitive delivery order is set to be completed by August 19, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $41,202.03 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-competitive, firm fixed-price delivery order is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $28,845.70 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pens on October 29, 2025, with an ultimate completion date of October 30, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The product will be delivered to the company's headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,735.65 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pens on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a continuation of the company's ongoing pharmaceutical supply relationship with the federal government. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,895.53 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on October 30, 2025, with an ultimate completion date of October 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a $12,870.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pens on August 26, 2025, with an ultimate completion date of August 27, 2025. This non-set-aside contract represents a direct fulfillment order under AmerisourceBergen's existing Defense Logistics Agency contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,605.03 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 25, 2025, with an ultimate completion date of August 26, 2025. This contract utilizes a firm fixed-price structure under a competitively awarded vehicle with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...
- SPE2DR25D2002Indefinite Delivery Contract
- SPE2DR25D2002-SPE2DR26FBRS2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,220.46 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens on November 4, 2025, with an ultimate completion date of November 5, 2025. This is a firm fixed price delivery order issued under a competitive procurement with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a major pharmaceutical distributor for federal medical procurement needs. This delivery order represents a single transaction within AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare systems worldwide, including support for the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's demonstrated capability to fulfill federal medical supply requirements through open competition is reflected in its extensive portfolio of competitively awarded contracts covering diverse therapeutic categories and transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.2k | 11/4/25 |